Literature DB >> 4324813

Inhibition of growth of uninfected and rous sarcoma virus-infected chick-embryo fibroblasts by rifampicin.

H L Robinson, W S Robinson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4324813

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  11 in total

1.  Membrane proteins of uninfected and Rous sarcoma virus- transformed avian cells.

Authors:  R H Bussell; W S Robinson
Journal:  J Virol       Date:  1973-08       Impact factor: 5.103

2.  Induction of cytotoxic action by rifamycin in a system of normal allogeneic lymphocytes-target cells in vitro.

Authors:  A S Berman
Journal:  Bull Exp Biol Med       Date:  1974-10       Impact factor: 0.804

3.  RNA polymerase activity in human brain tumors.

Authors:  D E Slagel
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

4.  Effects of polyadenylic acids on functions of murine RNA tumor viruses.

Authors:  R W Tennant; J G Farrelly; J N Ihle; B C Pal; F T Kenney; A Brown
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

5.  Synergistic effect of rifamycin derivatives and amphotericin B on viral transformation of a murine cell line.

Authors:  A J Hackett; S S Sylvester; U R Joss; M Calvin
Journal:  Proc Natl Acad Sci U S A       Date:  1972-12       Impact factor: 11.205

6.  Lack of specific inhibition of Vaccinia plaque formation by bacteriophage lambda products.

Authors:  A Brown; S N Cohen
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

7.  Differential susceptibility of spleen focus-forming virus and murine leukemia viruses to ansamycin antibiotics.

Authors:  J S Horoszewicz; S S Leong; W A Carter
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

8.  RNA-directed DNA polymerase and virus-induced leukemia in mice.

Authors:  A M Wu; R C Ting; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

9.  Mechanism of oncogenic transformation by Rous sarcoma virus. II. Effect of rifampin on Rous sarcoma virus infection.

Authors:  N J Richert; P Balduzzi
Journal:  J Virol       Date:  1971-07       Impact factor: 5.103

10.  Preferential inhibition of the growth of virus-transformed cells in culture by rifazone-82, a new rifamycin derivative.

Authors:  M J Bissell; C Hatie; A N Tischler; M Calvin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.